a | b | c | d | e | f | g | h | i | j | k | l | m | n | o | p | q | r | s | t | u | v | w | x | y | z
| Subjects listed in alphabetical order | ||||
| Subject | Pg. # | Subject | Pg. # | |
| Abuscreen‚ ONLINE | 265 | Acetaminophen | 118,366 | |
| Acetylampetamine, N- | 125 | Adderall | 485 | |
| Administration | 386 | Adulteration | 36 | |
| Alcohol | 57,253 | Alkaloids | 53,123 | |
| Ambient airborne level | 453 | Amitriptyline | 353 | |
| Amphetamine | 15,68,78,95,123, 125,135,205,253,265, 318,429,471,479,485,552 |
Amphetamine excretion | 485 | |
| AnaSed‚ | 110 | Antibody binding sites | 342 | |
| Antidepressant drugs | 30,57,353 | Antiepileptic drugs | 304,323 | |
| Antipsychotic drugs | 30 | APCI-MS–MS | 309 | |
| Aqueous samples | 309 | Arsenic | 372 | |
| Atrazine | 569 | Attempted suicide | 118 | |
| Automated broad-spectrum drug screening | 325 | Aviation accidents | 145 | |
| Subject | Pg. # | Subject | Pg. # | |
| Baclofen | 275 | Bentazon | 113 | |
| Benzodiazepine | 47,57,205,505,527 | Benzoylecgonine | 125,205,270, 383,407,453 | |
| Bile, human | 110 | Biocide | 372 | |
| Biological fluids, human | 88 | Biosensors, bacterial | 372 | |
| Blood, human | 30,113,145,257, 318,323,381,493,499, 517,523,527 |
Blood-alcohol content | 167 | |
| Brain, human | 30,145,381 | Brompheniramine | 523 | |
| Buprenorphine | 103,464,527 | Butalbital | 145 | |
| Subject | Pg # | Subject | Pg # | |
| Caffeine | 520 | Calcium antagonist | 68 | |
| Calliphora vicina | 505 | CAMI | 145 | |
| Cannabinoids | 57,106,205,253,429 | Cannabis | 106 | |
| Capillary gas–liquid chromatography | 353 | Carbamazepine | 243,304 | |
| Carbamazepine 10 | ,11 | epoxide | 304 | |
| Cardiac anti-arrhythmics | 47 | Cardiac blood, human | 257 | |
| Carisprodol | 118,275 | CE | 36 | |
| Central nervous system | 275 | Chloralose, a- | 156 | |
| Chromate adulteration | 36 | Citalopram | 113 | |
| Clofazimine | 377 | Clomipramine | 353 | |
| Clostebol | 213 | Cocaine | 57,125,205,253,270, 386,407,429,453,587 | |
| Codeine | 53,103,346,402,412,449 | Coffee | 520 | |
| Colorimetric methods | 36 | Column-switching LC–MS | 95 | |
| Confirmation analysis | 205 | Confirmation cutoffs | 402 | |
| Cozart‚ Opiate Microplate EIA | 402,581 | Cozart‚ RapiScan Oral Fluid Drug Testing System | 407 | |
| Crime laboratory personnel | 453 | Cutoff concentrations | 169 | |
| Cyanide | 372 | |||
| Subject | Pg # | Subject | Pg # | |
| DAD | 47,113,205,233,304 | DAWN-based classification scheme | 57 | |
| Decaffeinated specialty coffee | 520 | Department of Defense | 265 | |
| Designer drugs | 313,318,560 | Desmethylselegiline | 135 | |
| Dextromethorphan | 103,523 | Dextromoramide | 103 | |
| Dihydrocodeine | 103 | Dimethoxy-4-n-propyl- thiophenethylamine, 2,5- | 493 | |
| Distribution study | 318 | Doping control | 106 | |
| Dose/concentration relationship | 20 | DRI‚ | 265 | |
| Driving under the influence | 167, 552 | Drug binding | 125 | |
| Drug-facilitated sexual assault | 527,574 | Drug screening | 226,243,294,325, 402,407,412,449 | |
| Drug treatment programs | 149,412 | Drugs of abuse | 57,110,169,205,243, 386,407,429,459 | |
| Subject | Pg # | Subject | Pg # | |
| Ecgonine methyl ester | 270,407 | Electrospray ionization | 1,7,95, 103, 118,257,284,513 | |
| ELISA | 103,213,342,402,407,581,587 | Endogenous GHB, human | 40 | |
| Enzyme immunoassay | 103 | Ephedra | 123 | |
| Ephedrine | 78,265,359 | Ethanol | 167,243,323,517 | |
| Ethyldiethanolamine, N- | 1 | Ethylmorphine | 103 | |
| Eumelanins | 125,149 | Excretion patterns | 386 | |
| Subject | Pg # | Subject | Pg # | |
| FAA | 145 | False-negative results | 386 | |
| Famprofazone | 479 | Fatality | 47,318,323, 493,499, 523,527,595 | |
| Fatality, infant | 523 | Femoral blood, human | 257,493 | |
| Fentanyl | 499,513 | FID | 221 | |
| Flecainide | 47 | Fluoxetine | 353 | |
| Foxy | 313 | FPIA | 68 | |
| Furfural | 43 | Furoic acid | 43 | |
| Subject | Pg # | Subject | Pg # | |
| Gastric juice | 257 | GBL | 40 | |
| GC | 24,40,47,53,68,74, 106,113,123,135,156,162, 169,173,205,213,221,226, 243,265,270,294,309,313, 325,342,346,359,402,407, 445,449,471,479,485,493, 499,520,523,552,560 | |||
| GC–FID | 221 | GC–ion trap-MS–MS | 24 | |
| GC–MS | 40,47,53,68,74,106, 123,135,156,162,173,205, 213,221,226,249,265,270, 294,313,342,359,381,402, 407,449,471,479,485,493, 499,523,560 | |||
| GC–MS–MS | 169 | GC–NICI-MS | 552 | |
| GC–NPD | 47,113,359,493,520,523 | GC–PCI-MS | 270,445 | |
| General unknown screening | 7 | Gewodine‚ | 479 | |
| GHB | 40,445,574 | Glucornides | 464 | |
| Gluphosinate | 162 | Glycols | 173 | |
| Glyphosate | 162 | |||
| Subject | Pg # | Subject | Pg # | |
| Hair color | 149,545 | Hair, human | 20,95,135,145,149, 412,527,545,574,581 | |
| Hallucinogens | 381 | Heart blood, human | 110,493 | |
| Hedera helix | 257 | Hederacoside C | 257 | |
| Hederagenin | 257 | Hederin, a- | 257 | |
| Hepatic carboxylesterase hCE-1, human | 142 | Hepatic degradation, human | 142 | |
| Herbal products | 123 | Herbicide | 162,372 | |
| Heroin | 449,464 | HPLC | 43,47,88,103,113,149, 205,233,284,377,592 | |
| HPLC–DAD | 47,113,205,233 | HPLC–ES-MS | 103 | |
| HPLC–MS | 88 | |||
| Subject | Pg # | Subject | Pg # | |
| Immunochemical methods | 15,205 | Immunoassay | 15,169,205,243,265, 294,332,366,471 | |
| Impairment prediction | 383 | Inorganic poisons | 372 | |
| Intercept‰ immunoassay | 169 | Intoxication case | 593 | |
| In vitro | 125,142 | Industrial solvent | 43 | |
| International Olympic Committee | 53,359 | Ion-trap MS | 24 | |
| Subject | Pg # | Subject | Pg # | |
| Subject | Pg # | Subject | Pg # | |
| Kidney, human | 110,145 | |||
| Subject | Pg # | Subject | Pg # | |
| Lamotrigine | 304 | Large-volume injection GC–MS | 325 | |
| Larvae | 505 | LC | 1,7,15,30,78,95,118, 257,275,309,318,412, 440,459,464,505,513,527 | |
| LC–EI–MS | 7,95 | LC–EI-MS–MS | 1,257 | |
| LC–MS | 30,118,275,309,412,459,527 | LC–MS–MS | 15,78,441,464,505,513 | |
| LC–sonic spray ionization-MS | 318 | Leprosy patients | 377 | |
| Lioresel‚ | 275 | Liquid–liquid extraction | 40,74,88, 270,309,318,353,381, 445,479,493,513,520 | |
| Liver, human | 30,110,142,145,323, 381,493,523 | LSD | 24,243,459 | |
| LSD, O-H- | 459 | Lung, human | 145 | |
| Subject | Pg # | Subject | Pg # | |
| Maprotiline | 353 | Marijuana | 57 | |
| MDA | 15,78,265,471,552 | MDEA | 78,552 | |
| MDMA | 15,78,253,265,294, 318,471,552 | MECC | 304 | |
| Medication compliance | 135 | Melanin | 125,135 | |
| Meperidine | 142 | Meprobamate | 118 | |
| Mercury | 372 | Mescaline | 381 | |
| Metabolic profile | 243,386,479,560 | Metformin | 592 | |
| Methadone | 20,103,205,332, 464,479,499 | Methadone maintenance | 20,332 | |
| Methamphetamine | 78,95,123,135, 265,429,471,552 | Methamphetamine metabolites | 95 | |
| Methemoglobinemia | 221 | Methotrimeprazine | 323 | |
| Methyldiethanolamine, N- | 1 | Methylephedrine | 359 | |
| Methylphenidate | 342 | Monacetylmorphine, 6- | 103 | |
| Morphine | 53,103,402,412,449 | Muscle, human | 145 | |
| MS | 7,30,40,47,53,68, 74,88,95,103,106,118, 123,135,156,162,173,205, 213,221,226,243,265,270, 275,294,309,313,325,342, 359,381,402,407,412,445, 449,459,471,479,485,493, 499,523,527,552,560 | |||
| Subject | Pg # | Subject | Pg # | |
| Narcotics | 57,346 | Nefazodone | 560 | |
| Negative control | 602 | NICI-MS | 552 | |
| Nitrobenzene | 221 | Nitrogen mustards | 1 | |
| NMR spectroscopy, 1H- | 156 | Non-overdose cases | 145 | |
| Norbuprenorphine | 464 | Nordiazepam | 505,527 | |
| Norfentanyl | 513 | Nortriptyline | 353 | |
| NPD | 47,113,353,359, 381,493,520,523 | |||
| Subject | Pg # | Subject | Pg # | |
| Occupational exposure | 43,453 | Ofloxacin | 149 | |
| Opiates | 24,53,57,103,205,346, 402,412,429,449,527,581 | Opioid | 499 | |
| OPLC | 226 | Oral fluid, human | 78,169,402, 407,429,449 | |
| Over-the-counter cold medicines | 359,523 | Oxaxepam | 505 | |
| Oxycodone | 57,346,499 | Oxycodone postmortem database | 57 | |
| Oxycontin‚ | 57,346 | |||
| Subject | Pg # | Subject | Pg # | |
| Paraoxon activity | 290 | Parkinson patients | 135 | |
| PCB congeners | 74 | PCI-MS | 270,445 | |
| PEMA | 304 | Peripheral (subclavian) blood, human | 110 | |
| Personal breathing zone | 453 | Peyote cactus | 381 | |
| Phenobarbitol | 304,323 | Phenylpropandamine | 359 | |
| Pholocodeine | 103 | Phthalate ether metabolites | 284 | |
| Piperazine | 560 | Plasma, human | 74,78,113,118,135,145,304,366,377,445, 513,552,569 | |
| Plasticizers | 309 | PMA | 253,318 | |
| PMMA | 253 | Point-of-collection testing devices | 429 | |
| Poisoning | 113,156,162,221, 253,257,372 | Polychlorinated biphenyl residues | 74 | |
| Poppy seeds | 53,449 | Positive prevalence rates | 169 | |
| Postmortem blood, human | 47,253,517,587 | Postmortem fluid | 145,243 | |
| Postmortem investigation | 243,493,499 | Postmortem redistribution | 533 | |
| Postmortem specimens | 592 | Postmortem tissue, human | 145,243,381 | |
| Postmortem urine, human | 47 | Prenylamine | 68 | |
| Primidone | 304 | Procainamide | 142 | |
| Propafenone | 597 | Propoxyphene | 103 | |
| Pseudoephedrine | 265,359,523 | Puparia | 505 | |
| Subject | Pg # | Subject | Pg # | |
| Quinidine | 142 | |||
| Subject | Pg # | Subject | Pg # | |
| Reference marker | 149 | RIA | 123 | |
| Ritalin‚ | 342 | Rodenticide | 156 | |
| Rompun‚ | 110 | Roundup‚ herbicide | 162 | |
| RP-HPLC–EI-MS–MS | 284 | |||
| Subject | Pg # | Subject | Pg # | |
| Salicylate | 366 | Saliva, human | 88,270 | |
| Sedazine‚ | 110 | Selegiline | 135 | |
| Serotonergic drugs | 30 | Serotonin | 440 | |
| Serum, antemortem | 593 | Serum, bovine | 275 | |
| Serum, human | 7,156,162,253, 284,290,366 | Sildenafil citrate | 88 | |
| Soma‚ | 275 | Sonic spray ionization-MS | 318 | |
| Spanish population | 290 | SPE | 1,7,68,74,213,226, 257,284,309,353,459,464,499 | |
| Specialty coffee | 520 | Spleen, human | 145 | |
| Sports doping | 53,359 | Stomach contents, human | 30,323 | |
| Storage stability | 517 | Strychnine | 113 | |
| Substance identification | 233 | Subutex‚ | 527 | |
| Succinylmonocholine | 600 | Suffocation | 257 | |
| Suicide | 47,110,113,221,257 | Sweat testing | 294 | |
| Subject | Pg # | Subject | Pg # | |
| Tandem MS | 1,15,24,78, 125,169,257,284,309, 440,464,505,513 | Tetrahydrocannabinol | 253 | |
| THC | 106 | THC-COOH | 106 | |
| Tissue distribution | 110 | Topiramate | 323 | |
| Toxic chemical detection | 372 | Transdermal patches | 499 | |
| Trazodone | 353,560 | Trimipramine | 353 | |
| Triptomine | 313 | |||
| Subject | Pg # | Subject | Pg # | |
| Urine, bovine | 213 | Urine, horse | 325 | |
| Urine, human | 1,15,30,36,43,53,103, 106,110,113,118,123,156, 162,226,243,257,265,313, 318,332,342,346,359,372, 383,386,412,449,453,464, 479,485,499 | |||
| Urine, rat | 560 | Urine-alcohol concentration | 167 | |
| Urine/blood rations, human | 167 | U.S. EPA | 309 | |
| UV spectra library | 233 | |||
| Subject | Pg # | Subject | Pg # | |
| Viagra‚ | 88 | Vitreous fluid, human | 30,323, 381,517 | |